Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
4.800
+0.200 (4.35%)
At close: Nov 6, 2026, 4:00 PM EST
4.810
+0.010 (0.21%)
After-hours: Nov 6, 2026, 7:30 PM EST

Cytosorbents Revenue

Cytosorbents had revenue of $9.63M in the quarter ending June 30, 2026, with 0.17% growth. This brings the company's total for the last twelve months to $37.22M, up 3.07% year-over-year. In the year 2025, Cytosorbents had annual revenue of $37.06M with 4.12% growth. That makes Cytosorbents the 29,983rd largest company in the world by revenue and 3,972nd in the United States.

Revenue (ttm)
$37.22M
Revenue Growth
+3.07%
P/S Ratio
0.41
Revenue / Employee
$288,496
Employees
129
Market Cap
15.13M

Revenue Chart

Revenue by Geography

  • ALL Other Countries 25.06M 67.6%
  • Germany 11.75M 31.7%
  • United States 249.00K 0.7%
Fiscal year ended Dec 31, 2025 See the full Cytosorbents breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202537.06M1.47M4.12%
Dec 31, 202435.60M4.51M14.51%
Dec 31, 202331.08M-3.60M-10.39%
Dec 31, 202234.69M-8.48M-19.64%
Dec 31, 202143.17M2.16M5.27%
Dec 31, 202041.00M16.06M64.35%
Dec 31, 201924.95M2.45M10.87%
Dec 31, 201822.50M7.35M48.53%
Dec 31, 201715.15M5.62M59.02%
Dec 31, 20169.53M4.74M98.84%
Dec 31, 20154.79M668.79K16.22%
Dec 31, 20144.12M1.70M70.18%
Dec 31, 20132.42M1.08M80.40%
Dec 31, 20121.34M1.31M3,622.31%
Dec 31, 201136.08K--
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Accuray394.53M
IRIDEX51.57M
SANUWAVE Health44.02M
Lifeward21.82M
Nano-X Imaging15.63M
Pulsenmore14.13M
Picard Medical6.30M
Sintx Technologies1.33M
Revenue Rankings